Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts

Journal of Bacteriology

Volumn 178, Issue 20, 1996, Pages 5867-5876

  Freer, Enrique ^a,b   Moreno, Edgardo ^c   Moriyón, Ignacio ^d   Pizarro Cerdá, Javier ^e   Weintraub, Andrej ^b   Gorvel, Jean Pierre ^e  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSIDAD NACIONAL   (Costa Rica)

^d UNIVERSITY OF NAVARRA   (Spain)

^e CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CATION; EDETIC ACID; FLUORESCENT DYE; PEPTIDE; POLYMYXIN B;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BRUCELLA ABORTUS; CHIMERA; FLUOROMETRY; HYDROPHOBICITY; MEMBRANE BINDING; MEMBRANE PERMEABILITY; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SALMONELLA; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MONTEVIDEO;

EID: 0029795690     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.178.20.5867-5876.1996     Document Type: Article

References (48)

1. Aragon, V., R. Díaz, E. Moreno, and I. Moriyón. 1996. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J. Bacteriol. 178:1070-1079.
2. Baker, P. J., and J. B. Wilson. 1965. Chemical composition and biological properties of endotoxin of Brucella abortus. J. Bacteriol. 90:895-902.
3. Canning, P. 1990. Phagocyte function in resistance to brucellosis, p. 151-163. In L. G. Adams (ed.), Advances in brucellosis research. Texas A&M University Press, College Station.
4. Caroff, M., D. R. Bundle, and M. B. Perry. 1984. Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica O:9. Ear. J. Biochem. 139:195-200.
5. Carr, C., and D. C. Morrison. 1985. Mechanism of polymyxin B-mediated lysis of lipopolysaccharide-treated erythrocytes. Infect. Immun. 49:84-89.
6. Cherwonogrodzky, J. W., G. Dubray, E. Moreno, and H. Mayer. 1990. Antigens of Brucella, p. 19-64. In K. Nielsen and B. Duncan (ed.), Animal brucellosis 1990. CRC Press, Inc., Boca Raton, Fla.
7. Cloeckaert, A., P. de Wergifosse, G. Dubray, and J. N. Limet. 1990. Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay. Infect. Immun. 58:3980-3987.
8. Corbel, M. J., and W. J. Brinley-Morgan. 1984. Genus Brucella. p. 377-388. In N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore.
9. Daniels, L., R. S. Hanson, and J. A. Phillips. 1994. Chemical analysis, p. 512-554. In P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C.
10. Douglas, J. T., E. Y. Rosenberg, H. Nikaido, D. R. Verstreate, and A. T. Winter. 1984. Porins of Brucella species. Infect. Immun. 44:16-21.
11. Feingold, D. S., C. C. Hsu-Chen, and I. J. Sud. 1974. Basis for the selectivity of action of the polymyxin antibiotics on cell membranes. Ann. N. Y. Acad. Sci. 235:480-492.
12. Fields, P. I., E. A. Groisman, and F. Heffron. 1989. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 243:1059-1062.
13. Freer, E., N. Rojas, A. Weintraub, A. Lindberg, and E. Moreno. 1995. Heterogeneity of Brucella abortus lipopolysaccharides. Res. Microbiol. 146: 569-578.
14. Gamazo, C., and I. Moriyón. 1987. Release of outer membrane fragments by exponentially growing Brucella melitensis. Infect. Immun. 55:609-615.
15. Gilleland, H. E., Jr., and R. G. E. Muray. 1976. Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa. J. Bacteriol. 125: 267-281.
16. Goldstein, J., T. Hoffman, C. Frasch, E. F. Lizzio, P. R. Beining, D. Hochstem, Y. L. Lee, D. Angus, and B. Golding. 1992. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun. 60:1385-1389.
17. Gómez-Miguel, M. J., I. Moriyón, and J. López. 1987. Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface. Infect. Immun. 55:258-262.
18. Heiander, I. M., K. Nummila, I. Kilpeläinen, and M. Vaara. 1995. Increased substitution of phosphate groups in lipopolysaccharides and lipid A of polymyxin-resistant mutants of Salmonella typhimurium and Escherichia coli, p. 15-23. in J. Levin, C. R. Alving, R. S. Munford, and H. Redl (ed.), Bacterial endotoxins: lipopolysaccharides from genes to therapy. Wiley-Liss, Inc., New York.
19. Hsu-Chen, C. C., and D. S. Feingold. 1973. The mechanism of polymyxin B action and selectivity toward biological membranes. Biochemistry 12:2105-2111.
20. Khun, H., B. Samanta, and H. Mayer. 1987. Comparison of enterobacterial common antigen from different species by serological techniques. Eur. J. Biochem. 162:69-74.
21. Kreutzer, B. L., and D. C. Robertson. 1979. Surface macromolecules and virulence in intracellular parasitism: comparison of cell envelope components of smooth and rough strains of Brucella abortus. Infect. Immun. 23: 819-828.
22. Leive, L. 1974. The barrier function of the gram-negative envelope. Ann. N. Y. Acad. Sci. 235:109-129.
23. Leong, D., R. Díaz, K. Milner, J. Rudbach, and J. B. Wilson. 1970. Some structural and biological properties of Brucella endotoxin. Infect. Immun. 1:174-182.
24. Loh, B., C. Grant, and R. E. W. Hancock. 1984. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:546-551.
25. Martínez de Tejada, G., and I. Moriyón. 1993. The outer membranes of Brucella spp. are not barriers to Hydrophobic permeants. J. Bacteriol. 175: 5273-5275.
26. Martínez de Tejada, G., J. Pizarro-Cerdá, E. Moreno, and I. Moriyon. 1995. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect. Immun. 63:3054-3061.
27. Moreno, E. 1992. Evolution of Brucella, p. 198-218. In M. Plommet (ed.), Prevention of brucellosis in the Mediterranean countries. Pudoc, Wageningen. The Netherlands.
28. Moreno, E., D. T. Berman, and L. A. Boettcher. 1981. Biological activities of Brucella abortus lipopolysaccharides. Infect. Immun. 31:362-369.
29. Moreno, E., L. M. Jones, and D. T. Berman. 1984. Immunochcmical characterization of rough Brucella lipopolysaccharides. Infect. Immun. 43:779-782.
30. Moreno, E., M. W. Pitt, L. M. Jones, G. G. Schurig, and D. T. Berman. 1979. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J. Bacteriol. 138:361-369.
31. Moreno, E., E. Stackebrandt, M. Dorsh, J. Wolters, M. Busch, and H. Mayer. 1990. Brucella abortus 16S rRNA and lipid A reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class Proteobacteria. J. Bacteriol. 172:3569-3576.
32. Moriyon, I., and D. T. Berman. 1982. Effects of nonionic, ionic, and dipolar ionic detergents and EDTA on Brucella cell envelope. J. Bacteriol. 152:822-828.
33. Moriyon, I., C. Gamazo, and R. Diaz. 1987. Properties of the outer membrane of Brucella. Ann. Inst. Pasteur/Microbiol. (Paris) 138:89-91.
34. Moriyon, I., and M. A. Montanes. 1985. In vitro interactions between lipopolysaccharides and heterologous outer membrane proteins. Curr. Microbiol. 12:229-234.
35. Rasool, O., E. Freer, E. Moreno, and C. Jarstrand. 1992. Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect. Immun. 60:1699-1702.
36. Ribi, E., R. L. Anacker, R. Brown, W. T. Haskins, B. Maimgren, K. C. Milner, and J. A. Rudbach. 1966. Reaction of cndotoxin and surfactants. J. Bacteriol. 92:1492-1506.
37. Robinson, D. G., U. Ehlers, R. Herken, B. Hermann, F. Mayer, and F.-W. Schürmann (ed.). 1987. Methods for TEM, procedure for double staining sections, p. 69-71. In Methods of preparation for electron microscopy. Springer-Verlag KG, Berlin.
38. Rojas, N., E. Freer, A. Weintraub, M. Rámirez, S. Lind, and E. Moreno. 1994. Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin. Diagn. Lab. Immunol. 1:206-213.
39. Rudbach, J. A., K. C. Milner, and E. Ribi. 1967. Hybrid formation between bacterial endotoxins. J. Exp. Med. 126:63-79.
40. Sawyer, J. G., N. L. Martin, and R. E. W. Hancock. 1988. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 56:693-698.
41. Smith, L. D., and T. A. Ficht. 1990. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17:209-230.
42. Thiele, O. W., and G. Schwinn. 1973. The free lipids of Brucella melitensis and Bordetella pertussis. Eur. J. Biochem. 34:333-344.
43. Träuble, H., and P. Overath. 1973. The structure of Escherichia coli membranes studied by fluorescence measurements of lipid phase transitions. Biochim. Biophys. Acta 307:491-512.
44. Tsai, C., and C. E. Frasch. 1982. A sensitive stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
45. Vaara, M., and T. Vaara. 1981. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob. Agents Chemother. 19:578-583.
46. Vaara, M., and T. Vaara. 1983. Polycations as outer membrane-disorganizing agents. Antimicrob. Agents Chemother, 24:114-122.
47. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-96.
48. Yamauchi, K., M. Tomita, T. J. Giehl, and R. T. Ellison III. 1993. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61:719-728.